Translational regulation of ANG II type 1 receptors in proliferating vascular smooth muscle cells
- 1 January 2006
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 290 (1) , R50-R56
- https://doi.org/10.1152/ajpregu.00448.2005
Abstract
The current study examined angiotensin receptor (ATR) regulation in proliferating rat aortic vascular smooth muscle cells (VSMCs) in culture. Radioligand competition analysis coupled with RNase protection assays (RPAs) revealed that angiotensin type 1a receptor (AT1aR) densities (Bmax) increased by 30% between 5 and 7 days in culture [Bmax(fmol/mg protein): day 5, 379 ± 8.4 vs. day 7, 481 ± 12, n = 3, P < 0.05] under conditions in which no significant changes in AT1aR mRNA expression occurred [in RPA arbitrary units (AU): day 5, 0.23 ± 0.01 vs. day 7, 0.24 ± 0.04, n = 4] or in mRNA synthesis determined by nuclear run-on assays [AU: day 5, 0.35 ± 0.14 vs. day 7, 0.33 ± 0.11, n = 5]. In contrast, polysome distribution analysis indicated that AT1aR mRNA was more efficiently translated in day 7 cells compared with day 5 [% of AT1aR mRNA in fraction 2 out of total AT1R mRNA recovered from the sucrose gradient: day 5, 20.9 ± 9.9 vs. day 7, 56.8 ± 5.6, n = 3, P < 0.001]. Accompanying the polysome shift was 50% less RNA-protein complex (RPC) formation between VSMC cytosolic RNA binding proteins in day 7 cells compared with 5-day cultures and the 5′ leader sequence (5′LS) of the AT1aR [5′LS RPC (AU): day 5, 0.62 ± 0.15 vs. day 7, 0.23 ± 0.03; n = 4, P < 0.05] and also with exon 2 [Exon 2 RPC (AU): day 5, 35.0 ± 5.7 vs. day 7, 17.2 ± 3.6; n = 4, P < 0.05]. Taken together, these results suggest that AT1aR expression is regulated by translation during VSMC proliferation in part by RNA binding proteins that interact within exon 2 in the 5′LS of the AT1aR mRNA.Keywords
This publication has 38 references indexed in Scilit:
- Translational Regulation of Angiotensin Type 1a Receptor Expression and Signaling by Upstream AUGs in the 5′ Leader SequencePublished by Elsevier ,2004
- Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injuryJournal of Vascular Surgery, 2004
- Candesartan for the treatment of hypertension and heart failureExpert Opinion on Pharmacotherapy, 2004
- Targeting the cell cycle machinery for the treatment of cardiovascular diseaseJournal of Pharmacy and Pharmacology, 2003
- Transcriptional Suppression of Rat Angiotensin AT1a Receptor Gene Expression by Interferon-γ in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1999
- Regulation of Cytosolic Proteins BindingcisElements in the 5′ Leader Sequence of the Angiotensin AT1Receptor mRNABiochemical and Biophysical Research Communications, 1998
- In vitroandin vivoeffects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationBritish Journal of Pharmacology, 1997
- Angiotensin Receptors and Their Therapeutic ImplicationsAnnual Review of Pharmacology and Toxicology, 1996
- Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1992
- Functional angiotensin II receptors in cultured vascular smooth muscle cells.The Journal of cell biology, 1982